news reports say Retension Pharmaceuticals, Inc. is expected to list on October 9, 2026
Retension Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is expected…
Biotech

#IPO #Biotech #PharmaceuticalPreparations #UnitedStates #IPONews #pharmaceuticals #PDE5inhibitors #cardiovascular